Skip navigation
Universidade Federal da Bahia |
Repositório Institucional da UFBA
Use este identificador para citar ou linkar para este item: https://repositorio.ufba.br/handle/ri/5447
Tipo: Artigo de Periódico
Título: Lack of association of indoleamine 2,3-dioxygenase polymorphisms with interferon-alpha-related depression in hepatitis C
Título(s) alternativo(s): Brain, Behavior, and Immunity
Autor(es): Almeida, Amanda Cristina Galvão Oliveira de
Quarantini, Lucas de Castro
Sampaio, Aline Santos
Lyra, André Castro
Parise, Carmen Lívia
Paraná, Raymundo
Oliveira, Irismar Reis de
Koenen, Karestan C.
Scippa, Ângela Marisa de Aquino Miranda
Guindalini, Camila
Autor(es): Almeida, Amanda Cristina Galvão Oliveira de
Quarantini, Lucas de Castro
Sampaio, Aline Santos
Lyra, André Castro
Parise, Carmen Lívia
Paraná, Raymundo
Oliveira, Irismar Reis de
Koenen, Karestan C.
Scippa, Ângela Marisa de Aquino Miranda
Guindalini, Camila
Abstract: Background: Major depression is a frequent adverse effect of interferon-alpha (IFN-a) therapy. Although the indoleamine 2,3-dioxygenase (IDO) enzyme seems to be involved in the pathophysiology of IFN-a-induced depression, no pharmacogenetic study has investigated whether variation in the IDO gene mod-ifies vulnerability to this adverse effect. Methods: A cross-sectional study assessing 277 hepatitis C patients recruited in two specialized outpa-tient clinics of Brazil. They were interviewed with the Mini International Neuropsychiatric Interview (MINI) approximately 1 month after the end of IFN-a plus ribavirin therapy. Genomic DNA of individuals was extracted from venous blood. Three IDO single-nucleotide polymorphisms (SNPs) were genotyped (rs3824259; rs10089084 and rs35099072).Results: MINI indicated that 21.3% of the sample met criteria for a major depressive episode during the course of IFN-a therapy. No association with the diagnosis of a major depressive episode during the course of IFN-a therapy was observed genotype or allele-wise (p > 0.05). Current major depression and/or current anxiety disorder was significantly associated with IFN-a-related depression (p < 0.005). However, gender, age, route of infection, result of the antiviral treatment, past history of substance use disorders, depression or any other psychiatric disorder showed no association with IFN-a-related depression (p > 0.05). Conclusions: Our results suggest no influence of the variants in the IDO gene and the diagnosis of inter- feron-a-related depression in the Brazilian population. Interferon-a-related depression may impose per-sistent psychopathology on at least 15% of the depressed patients even 2 years after antiviral therapy termination. The cross-sectional design is a limitation of our study, predisposing memory bias. Prospec- tive pharmacogenetic studies are warranted to continue investigation of the impact of IDO polymorphisms on the development of IFN-a-induced depression.
Palavras-chave: Genetic polymorphism
Major depressive disorder
Hepatitis C
Interferon-alpha
Pharmacogenetics
Substance-related disorders
URI: http://www.repositorio.ufba.br/ri/handle/ri/5447
Data do documento: 2011
Aparece nas coleções:Artigo Publicado em Periódico (Faculdade de Medicina)

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
nps67.tmp.pdf
  Restricted Access
106,81 kBAdobe PDFVisualizar/Abrir Solicitar uma cópia
Mostrar registro completo do item Visualizar estatísticas


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.